Japan To Subsidize Development Of Cancer-Targeted Diagnostic Drugs
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry has decided to subsidize research into developing diagnostic drugs for targeting specific cancer cells, according to sources.